Small head shot of Barbara Watson for use with blogs and testimonials

Lampalizumab Appears Safe for Dry Macular Degeneration

This is the first positive treatment result for patients with dry age-related macular degeneration and geographic atrophy.  Studies reveal that Lampalizumab reduced the atrophic area over an 18 months period. This is the first time that lampalizumab has been injected into humans. Phase 3 of clinical trials are underway. We look forward to the results.